This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MHVYF vs. PH: Which Stock Is the Better Value Option?
by Zacks Equity Research
MHVYF vs. PH: Which Stock Is the Better Value Option?
MHVYF vs. PH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MHVYF vs. PH: Which Stock Is the Better Value Option?
Parker-Hannifin's Exotic Metals Buyout to Aid Aerospace Group
by Zacks Equity Research
Parker-Hannifin's (PH) Exotic Metals buyout will be beneficial for organic sales, EBITDA margin, cash flow and earnings. The buyout is likely to boost opportunities for the aerospace business.
IDEX (IEX) Shares Up 31% YTD: What's Driving the Rally?
by Zacks Equity Research
IDEX (IEX) is likely to continue benefiting from solid product portfolio, favorable end markets, buyouts and growth investments.
Parker-Hannifin (PH) Down 4.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Parker-Hannifin (PH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Parker-Hannifin's (PH) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Parker-Hannifin's (PH) Q4 earnings rise but revenues fall on a year-over-year basis.
Parker-Hannifin (PH) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Parker-Hannifin (PH) delivered earnings and revenue surprises of 7.12% and 0.33%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Parker-Hannifin (PH) in Q4 Earnings?
by Zacks Equity Research
Strength in OEM and MRO businesses in both commercial and military end markets is likely to be boost Parker-Hannifin's (PH) fiscal Q4 results. High integration cost related to acquisition is a drag.
Earnings Preview: Parker-Hannifin (PH) Q4 Earnings Expected to Decline
by Zacks Equity Research
Parker-Hannifin (PH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Parker-Hannifin's Fuel Atomization Nozzles Chosen by Vericor
by Zacks Equity Research
Parker-Hannifin's (PH) fuel atomization nozzle and dual fuel manifold assembly will boost combustion performance of Vericor's oil field gas turbine.
Parker-Hannifin (PH) Down 10.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Parker-Hannifin (PH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for JHMM
Parker-Hannifin (PH) Q3 Earnings Top Estimates, Revenues Lag
by Zacks Equity Research
Parker-Hannifin's (PH) third-quarter fiscal 2019 revenues fall year over year due to softness in North American segment.
Parker-Hannifin (PH) Q3 Earnings Top Estimates
by Zacks Equity Research
Parker-Hannifin (PH) delivered earnings and revenue surprises of 5.32% and -0.67%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Parker-Hannifin (PH) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Strength across Parker-Hannifin's (PH) Diversified Industrial and Aerospace Systems segments will be conducive to its fiscal third-quarter results. High costs and expenses are concerns.
Parker-Hannifin (PH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Parker-Hannifin (PH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Cintas (CTAS) Maintain Beat Streak in Q3 Earnings?
by Zacks Equity Research
Strength in the Uniform Rental and Facility Services segment, accretive acquisitions and a solid product portfolio to drive Cintas' (CTAS) Q3 results.
Parker-Hannifin's Unit Boosts UK Site, Launches SciLog Suite
by Zacks Equity Research
The new testing facility at Birtley, U.K. site will aid Parker-Hannifin (PH) in delivering whole system solutions to biopharmaceutical manufacturing industry.
Parker-Hannifin (PH) Q2 Earnings, Revenues Beat Estimates
by Zacks Equity Research
Parker-Hannifin's (PH) second-quarter fiscal 2019 earnings and revenues jump year over year on the back of solid performance across Aerospace Systems and North American segments.
Parker-Hannifin (PH) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Parker-Hannifin (PH) delivered earnings and revenue surprises of 4.15% and 0.55%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Parker-Hannifin (PH) in Q2 Earnings?
by Zacks Equity Research
Strength in Diversified Industrial segment, OEM & aftermarket business in both commercial and military markets are conducive to Parker-Hannifin's (PH) Q2 fiscal 2019 results. High cost is a drag.
Parker-Hannifin (PH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Parker-Hannifin (PH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Parker-Hannifin (PH) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Parker-Hannifin (PH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Parker-Hannifin Displays Bright Prospects, Risks Persist
by Zacks Equity Research
Revamped Win Strategy, increased productivity and operating cost improvements are likely to drive Parker-Hannifin's (PH) organic growth amid headwinds.
This is Why Parker-Hannifin (PH) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Parker-Hannifin (PH) have what it takes? Let's find out.